Skip to main content
Premium Trial:

Request an Annual Quote

Scope Fluidics Secures €10M Loan From European Investment Bank

NEW YORK — The European Investment Bank (EIB) said on Tuesday that it will lend up to €10 million ($11.8 million) to Polish startup Scope Fluidics to assist with the development of infectious disease diagnostics.

Scope's product pipeline includes a point-of-care molecular diagnostic instrument called PCR One and a related rapid multiplex respiratory virus panel that includes SARS-CoV-2, influenza, and respiratory syncytial virus, as well as an antibiotic susceptibility testing system called BacterOmic that uses hundreds of independent culturing zones within a microfluidic cartridge to determine minimum inhibitory concentrations for antibiotics.

Scope expects to submit PCR One with a SARS-CoV-2 test to the US Food and Drug Administration for Emergency Use Authorization by the end of the year. 

EIB, the lending arm of the European Union, said the loan is being provided to Scope under the Infectious Diseases Financing Facility of the EU's Horizon 2020 research funding program.

In February, Scope raised 14 million Polish zloty ($3.7 million) through a share issuance. 

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.